Skip to main content
. 2016 May 1;5(3):115–122. doi: 10.1530/EC-16-0003

Table 2.

Distribution of allele lengths for the IGF1 STR in the healthy controls, breast cancer cohorts and endometrial cancer cohorts.

CA<19 CA=19 CA>19 n
Healthy controls 58 (13.2%) 299 (67.9%) 83 (18.9%) 440
Breast cancer cohorts 67 (15.2%) 299 (67.6%) 76 (17.2%) 442
Endometrial cancer cohorts 61 (15.6%) 284 (72.8%) 45 (11.5%) 390

The actual number of allele lengths observed is shown with the percentage of total number of alleles enclosed by parentheses.